Octagon Capital Advisors is a New York-based healthcare and life sciences investment firm investing globally in public and private healthcare companies. The firm builds long-term positions, emphasizes science-driven conviction and clinical judgment, and focuses on public therapeutics as well as long-term private and structured transactions. Its private activity includes later-stage biotechnology and pharmaceutical financings, and it has acted as a lead investor, making it relevant for biopharma and oncology companies seeking later-stage capital.